The Role of Neuroinflammation in Neurodegenerative Diseases: Current Understanding and Future Therapeutic Targets

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2024 Apr 29

PMID 38681666

Authors

Alhamdu Adamu

Shuo Li

Fankai Gao

Guofang Xue

Affiliations

Soon will be listed here.

Abstract

Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson's disease, Alzheimer's, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders.

Citing Articles

The Role of G-Protein-Coupled Receptor Kinase 4 in Modulating Mitophagy and Oxidative Stress in Cerebral Ischemia-Reperfusion Injury.

Wang J, Gu D, Jin K, Shen H, Qian Y Neuromolecular Med. 2025; 27(1):21.

PMID: 40055267 DOI: 10.1007/s12017-025-08843-3.

Deciphering the Neuroprotective Action of Bee Venom Peptide Melittin: Insights into Mechanistic Interplay.

Kadyan P, Singh L Mol Neurobiol. 2025; .

PMID: 40038194 DOI: 10.1007/s12035-025-04808-6.

Modulation of the Neuro-Cancer Connection by Metabolites of Gut Microbiota.

Mafe A, Busselberg D Biomolecules. 2025; 15(2).

PMID: 40001573 PMC: 11853082. DOI: 10.3390/biom15020270.

Meroterpenoids from Terrestrial and Marine Fungi: Promising Agents for Neurodegenerative Disorders-An Updated Review.

Dimitrova D, Dimitrova S, Kehayova G, Dragomanova S Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996817 PMC: 11854780. DOI: 10.3390/cimb47020096.

Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review.

Jalouli M, Rahman M, Biswas P, Rahman H, Harrath A, Lee I Front Pharmacol. 2025; 16:1492517.

PMID: 39981183 PMC: 11840759. DOI: 10.3389/fphar.2025.1492517.

References

Salehi B, Mishra A, Nigam M, Sener B, Kilic M, Sharifi-Rad M . Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines. 2018; 6(3). PMC: 6164842. DOI: 10.3390/biomedicines6030091. View

Han Q, Le W . NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson's Disease. Neurosci Bull. 2023; 39(5):832-844. PMC: 10169990. DOI: 10.1007/s12264-023-01023-y. View

Clayton K, Van Enoo A, Ikezu T . Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy. Front Neurosci. 2018; 11:680. PMC: 5733046. DOI: 10.3389/fnins.2017.00680. View

Ben Haim L, Carrillo-de Sauvage M, Ceyzeriat K, Escartin C . Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci. 2015; 9:278. PMC: 4522610. DOI: 10.3389/fncel.2015.00278. View

Pasko V, Churkina A, Shakhov A, Kotlobay A, Alieva I . Modeling of Neurodegenerative Diseases: 'Step by Step' and 'Network' Organization of the Complexes of Model Systems. Int J Mol Sci. 2023; 24(1). PMC: 9820769. DOI: 10.3390/ijms24010604. View

Zhou Y, Chen Y, Xu C, Zhang H, Lin C . TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment. Front Neurosci. 2021; 14:602508. PMC: 7775514. DOI: 10.3389/fnins.2020.602508. View

Ghasemi N, Razavi S, Nikzad E . Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J. 2017; 19(1):1-10. PMC: 5241505. DOI: 10.22074/cellj.2016.4867. View

Xu Y, Chen A, Wu J, Wan Y, You M, Gu X . Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke. Int J Nanomedicine. 2022; 17:1927-1950. PMC: 9075782. DOI: 10.2147/IJN.S357598. View

Shao F, Wang X, Wu H, Wu Q, Zhang J . Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration. Front Aging Neurosci. 2022; 14:825086. PMC: 8990307. DOI: 10.3389/fnagi.2022.825086. View

10.

Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M . The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017; 15(1):23. PMC: 5480189. DOI: 10.1186/s12964-017-0177-y. View

11.

Zhang Z, Yan Q, Wu W, Zhao Y, Zhang H, Li J . PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis. J Int Med Res. 2023; 51(6):3000605231177191. PMC: 10278420. DOI: 10.1177/03000605231177191. View

12.

Deming Y, Li Z, Benitez B, Cruchaga C . Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?. Expert Opin Ther Targets. 2018; 22(7):587-598. PMC: 6295143. DOI: 10.1080/14728222.2018.1486823. View

13.

Ochocka N, Kaminska B . Microglia Diversity in Healthy and Diseased Brain: Insights from Single-Cell Omics. Int J Mol Sci. 2021; 22(6). PMC: 8002227. DOI: 10.3390/ijms22063027. View

14.

Zhang X, Tang B, Guo J . Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl Neurodegener. 2023; 12(1):59. PMC: 10722742. DOI: 10.1186/s40035-023-00392-8. View

15.

Hernandez A, Garcia E . Mesenchymal Stem Cell Therapy for Alzheimer's Disease. Stem Cells Int. 2021; 2021:7834421. PMC: 8426054. DOI: 10.1155/2021/7834421. View

16.

Harry G, Kraft A . Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol. 2008; 4(10):1265-77. PMC: 2658618. DOI: 10.1517/17425255.4.10.1265. View

17.

Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo P, Rosenstock T . New Avenues for the Treatment of Huntington's Disease. Int J Mol Sci. 2021; 22(16). PMC: 8394361. DOI: 10.3390/ijms22168363. View

18.

Chen W, Hu Y, Ju D . Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharm Sin B. 2020; 10(8):1347-1359. PMC: 7488363. DOI: 10.1016/j.apsb.2020.01.015. View

19.

Wu L, Xian X, Xu G, Tan Z, Dong F, Zhang M . Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease. Mediators Inflamm. 2022; 2022:7924199. PMC: 9420645. DOI: 10.1155/2022/7924199. View

20.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J . Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9(6):7204-7218. PMC: 5805548. DOI: 10.18632/oncotarget.23208. View